Vanda is a leading global biopharmaceutical company.

Vanda is a leading global biopharmaceutical company.

Vanda is developing important new medicines to improve the lives of patients. We use new technologies, including genetics and genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds. We are working to advance the use of novel approaches to deliver these new medicines to patients. Our CEO, Mihael Polymeropoulos, MD, founded Vanda in 2003 in partnership with Care Capital LLC, a prominent biopharmaceuticals-focused investment firm, and Bio*One Capital, an investment arm of the Singapore government with a focus on new biomedical enterprises.

Corporate Officers

Working together for a common goal.

BOARD OF DIRECTORS

Knowledge. Experience. Commitment.

BOARD OF DIRECTORS

Corporate Governance

Audit Committee

Richard W. Dugan (Financial Expert)
Chair, Member

Anne Sempowski Ward
Member

Phaedra Chrousos
Member

Compensation Committee

Anne Sempowski Ward
Chair, Member

Richard W. Dugan
Member

Tage Honoré, Ph.D., D.Sc.
Member

Nominating / Corporate Governance Committee

Phaedra Chrousos
Chair, Member

Stephen Ray Mitchell, MD, M.B.A.
Member

Tage Honoré, Ph.D., D.Sc.
Member